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Neuropsychological Impairment in Female Patients with Chronic Fatigue 
Syndrome: A preliminary study 
 
Abstract 
This study examines neuropsychological impairments associated with Chronic 
Fatigue Syndrome (CFS) and explores their association with related clinical factors. 
Sixty-eight women with CFS were assessed with a neuropsychological battery. Raw 
scores were adjusted for age and gender and converted to T-scores according to 
normative data extracted from a local sample of 250 healthy subjects. 
Neuropsychological dysfunction was calculated using summary impairment indices 
(proportion of test scores outside normal limits-T-score<40- for each cognitive domain). 
Finally, a linear regression was calculated to identify predictors of cognitive deficit, 
including intrinsic factors (level of fatigue and length of illness) and extrinsic factors 
(emotional factors, age and education) of the disease. Approximately 50% of scores 
showed impairment in attention and motor functioning, and nearly 40% in speed 
information processing and executive functioning. Fatigue predicted attention and 
executive functioning impairment, and emotional factors predicted verbal memory 
dysfunction. According to our findings, cognitive dysfunction in CFS could be 
explained by pathophysiological processes of the disease. One implication of this would 
be the need to identify homogeneous subgroups of CFS patients by taking into account 
common factors which, in turn, would help to identify more specific cognitive profiles, 
which could then serve to implement appropriate therapeutic measures accordingly. 
Key words: Cognitive Dysfunction, Chronic Fatigue Syndrome, Neuropsychological 
assessment 
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Introduction 
Chronic fatigue syndrome (CFS) is defined by severe and unexplained fatigue 
for at least 6 months, resulting in a substantial reduction of the patient’s quality of life 
(Fukuda et al., 1994). Cognitive dysfunction is one of the most common symptoms 
reported by CFS patients. About 89% of people with CFS complain of memory and 
concentration problems (Jason et al., 1999), and describe their cognitive difficulties as 
amongst the most disabling and troubling symptoms of their illness (Abbey & 
Garfinkel, 1991). However, objective measures of neuropsychological performance do 
not reflect the high magnitude of cognitive complaints. 
Cognitive deficits have been identified in the literature, although findings are 
inconsistent and hindered by methodological irregularities. Some studies show 
impairments in memory (Claypoole et al., 2007; Daly, Komaroff, Bloomingdale, 
Wilson, & Albert, 2001; DeLuca, Johnson, Ellis, & Natelson, 1997) and executive 
functioning (Claypoole, et al., 2007; Dobbs, Dobbs, & Kiss, 2001), whereas other 
studies do not (Ross, Fantie, Straus, & Grafman, 2001; Short, McCabe, & Tooley, 
2002). Busichio et al. (2004), for example, found that CFS patients showed deficits in 
attention, speed of information processing and motor speed, but not in memory and 
executive functioning. Other findings suggest that attention could be the primary 
cognitive dysfunction in CFS (DeLuca et al., 2004; Dickson, Toft, & O'Carroll, 2009), 
whereas other cognitive deficits, such as memory, could be secondary to this 
impairment. Overall, recent reviews conclude that the most common CFS related 
cognitive impairments are attention impairment (working memory and slowed reaction 
time) and reduced information processing speed (Cockshell & Mathias, 2010; Michiels 
& Cluydts, 2001). 
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The etiology of cognitive dysfunction in CFS is uncertain, and may have as its 
origin a wide spectrum of factors. One possible explanation is the effect of 
psychopathological factors (e.g. depression, anxiety) on cognitive performance in CFS. 
Patients with depression and anxiety may experience cognitive dysfunction (Marvel & 
Paradiso, 2004). Since depressive symptoms and anxiety are frequently observed in 
patients with CFS (Harvey, Wessely, Kuh, & Hotopf, 2009), the possibility that these 
may contribute to impaired cognitive performance must be considered. Some studies 
have found a relationship between cognitive deficits and depression and anxiety in CFS 
(Michiels & Cluydts, 2001; Tiersky et al., 2001). However, the majority of 
neuropsychological studies that have examined this relationship conclude that cognitive 
dysfunction in CFS is not a function of depression or anxiety (Busichio, et al., 2004; 
Short, et al., 2002). Consistent with this finding, in a recent study we found that 
cognitive dysfunction in CFS patients was independent of the presence of depression 
(Santamarina-Perez, Freniche, et al., 2011). Such findings are still preliminary, and, 
given the disparity of results, further research is still needed. 
Fatigue severity is another factor affecting cognitive performance, although 
there is very little research in this area and the findings are equivocal. The intensity of 
fatigue may reflect the severity of the disease, which in turn may negatively impact 
cognitive functioning. Both fatigue and cognitive deficits are present in organic 
diseases, and are a manifestation of brain dysfunction. In fact, some studies have 
compared CFS patients to patients with multiple sclerosis (MS), particularly because of 
the presence of fatigue and cognitive impairments in both disorders (Daly, Komaroff, 
Bloomingdale, Wilson, & Albert, 2001; DeLuca, Johnson, Beldowicz, & Natelson, 
1995). In this respect, Capuron et al. (2006) suggested that the level of fatigue could 
give an indication of the neural pathways that may underlie cognitive alterations in CFS 
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patients. However, other studies did not find a relationship between level of fatigue and 
cognitive performance in CFS (Short, et al., 2002).  
The duration of the illness may be another variable to consider. In clinical 
practice, most patients report a progressive worsening in their cognitive functioning 
over time which would appear to indicate that cognitive impairment is directly 
associated with CFS. However, empirical research does not confirm this hypothesis 
(Cope, Pernet, Kendall, & David, 1995; Tiersky, et al., 2001). In a recent study carried 
out by our team, we also conclude that there is no progressive cognitive dysfunction in 
patients with CFS (Santamarina-Perez, Eiroa-Orosa, et al., 2011).  
Based on the previous results, the purpose of this study is to identify 
neuropsychological impairments and their association with basic clinical factors in 
patients with CFS. As there were not enough male patients being treated for CFS in the 
hospital where the study took place, only women have been included in order to reduce 
the potential effect of gender differences on cognitive functioning. 
 
Method 
Participants 
The study sample consisted of 68 CFS patients who attended the Chronic 
Fatigue Unit of the Vall d’Hebron University Hospital in Barcelona (Spain), from 
October 2008 to February 2010. A diagnosis of CFS and being more than 18 years old 
were the inclusion criteria As only three men were treated during the data collection, 
they were excluded from the study  in order to reduce possible biases due to gender 
differences, . The exclusion criteria from the study were: 1) current or lifetime diagnosis 
of schizophrenia, mania, substance abuse or dependence (except nicotine), or an eating 
disorder; 2) current or lifetime neurological disorder; or 3) organic diseases that involve 
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cognitive alterations. Two patients were excluded because of eating disorders and one 
because of substance use disorder. 
Procedure 
Patients arrived at the Chronic Fatigue Unit of the University Hospital Vall 
d’Hebron, referred by a primary care physician or other medical services from the 
Hospital. At the unit, an internist confirmed CFS diagnosis in all patients by carrying 
out a physical examination and clinical laboratory studies. 
All patients who met the 1994 CFS case definition criteria (Fukuda, et al., 1994) 
were referred to the psychiatry department in order to complete a comprehensive 
assessment. The evaluation was carried out over two sessions. In the first one, a 
clinician interviewed the patient, recorded sociodemographic and clinical data, and 
conducted a clinical interview according to the Diagnostic and Statistical Manual of 
Mental Disorders (fourth edition, text revision) criteria (American Psychiatric 
Association, 2000).  
At the second assessment session, which took place within 2 weeks of the first, a 
neuropsychological assessment was carried out. All sessions were performed under 
standardized conditions and each one lasted 2 hours approximately. 
All participants received information about the study, and signed an informed 
consent form to participate. The study was approved by the Clinical Research Ethics 
Committee of the Hospital. 
Assessment 
Mood Assessment. 
The Hospital Anxiety and Depression Scale (HAD, Zigmond & Snaith, 1983) 
was administered to assess the level of anxiety and depression. This scale has been 
validated for use with CFS patients (Henderson & Tannock, 2005). The HADS does not 
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include items concerning somatic symptoms including fatigue. A score of 9 or more is 
the cut off for borderline anxiety or depression. 
Fatigue Assessment. 
The level of fatigue was evaluated with the Fatigue Impact Scale (FIS, Fisk et 
al., 1994). Consisting of 40 items, this instrument measures mental, physical, and 
psychosocial dimensions and yields a total index of fatigue, a score higher than 120 is 
considered a clinically significant fatigue. 
Neuropsychological Assessment. 
Neuropsychological tests were administered in a standardized manner. The 
selection of the battery used was based on previous studies (Busichio, et al., 2004; 
Claypoole, et al., 2007; Cockshell & Mathias, 2010), with the goal of assessing different 
cognitive domains. The instruments included were: Mental Control (WMS-III, 
Wechsler, 1997b), Paced Auditory Serial Addition Test (PASAT, Gronwall, 1977) , 
Digit Span (WAIS-III, Wechsler, 1997a), and Symbol Digit Modalities Test (SDMT, 
Smith, 1982); Stroop Test (Golden, 1978), Trail-Making Test (TMT, Reitan & Wofson, 
1985), Verbal Fluency Test (FAS, Benton & Hamsher, 1978), and the Tower of London 
test (Shallice, 1982); Rey Auditory Verbal Learning test (RAVLT, Rey, 1964) and Rey 
Complex Figure Test (RCFT(Rey, 1964) and Recognition Test (RT,(Meyers & Meyers, 
1995); Grooved pegboard (Klove, 1963); and vocabulary subtest of the WAIS-III 
(Wechsler, 1997a). Neuropsychological tests were translated and culturally adapted. 
This battery was validated on a general population sample of 250 healthy subjects, 
confirming no significant differences with the original parameters (please see below, 
categorization of neuropsychological tests). The sample of healthy subjects was selected 
from respondents to ads placed in the hospital, hospital staff, and acquaintances of 
patients. The age range was from 18 years to 65 years, 63% women.. 
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Categorization of neuropsychological tests. 
In this study, neuropsychological measures were categorized into 7 specific 
cognitive domains: Attention, speed of information processing, verbal memory, visual 
memory, executive functioning, problem solving and motor functioning. Each domain 
included measures that evaluated similar cognitive skills. This categorization was made 
taking previous studies as a reference (Busichio, et al., 2004; Claypoole, et al., 2007), 
and a validation using principal component analysis was carried out  (Santamarina-
Pérez et al., 2011) in order to assure the unidimensionality of each category. Table 1 
shows included tests, range of factor loads and reliability indices (Cronbach's alpha) for 
each category. 
Attention. 
The attentional domain consisted of the Digit Span forward subtest, the Mental 
Control, the number of words correct on trials 1 and 2 of the Stroop Color and Word 
Test, the Symbol Digit Modalities Test (SDMT) and Trail Making Test Part A (TMT). 
All of these measures are known to evaluate different aspects of attention function 
(Lezak, 1995). 
Speed of information processing. 
PASAT, a complex task of attention and information-processing ability was used 
to assess speed of information processing. In this study, we used a version that consists 
of showing 60 randomized digits to the patient in two blocks, every 3 and 2 seconds 
respectively. In each task, performance was evaluated in terms of correct responses. 
Verbal memory. 
This dimension was composed of the following measures: immediate recall (trial 
1, trial 5, trial 6), delayed recall and recognition from the RAVLT. 
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Table 1. Categorization, composition, construct validity* and reliability of cognitive 
functions 
Category Test Factor 
weight  
%Variance 
explained* 
Cronbach’s 
alpha 
Attention 
 
STROOP word 
STROOP colour 
Mental Control 
Digit span forward 
TMT A 
Symbol Digit 
0.926 
0.900 
0.873 
0.864 
0.790 
0.478 
67.1 .895 
Speed of 
information 
processing 
PASAT-2 
PASAT-3 
 
0.942 
0.942 
88.8 .874 
Verbal memory RAVLT inmediate 
recall-trial1 
RAVLT inmediate 
recall-trial 5 
RAVLT inmediate 
recall-trial 6 
RAVLT delayed 
recall 
RAVLT recognition 
0.544 
0.889 
0.952 
0.910 
0.897 
72.5 .895 
Visual memory RCFT delayed recall 
RCFT inmediate 
recall 
RT recognition 
0.936 
0.942 
0.630 
72.0 .794 
Executive 
functioning 
COWA 
Stroop word-colour 
TMT B 
Digit span backward 
RCFT copy 
0.782 
0.764 
0.762 
0.671 
0.569 
51.0 .756 
Problem solving TOL  total move 
score 
TOL perfect solutions 
0.943 
0.943 
88.9 .875 
Motor functioning Grooved Pegboard 
preferred hand 
Grooved Pegboard 
non preferred hand 
0.959 
0.959 
92.1 .914 
 
TMT: Trail Making Test; RT, reaction time; RAVLT indicates Rey Auditory Verbal Learning test; 
RCFT, Rey Complex Figure Test; RT, recognition trial;  COWA Controlled Oral Word Association Test; 
TOL, Tower of London. 
 
Principal components analyses with Varimax rotations were used to estimate factor weights. 
 
Visual memory. 
Immediate and delayed recall of the RCFT, and the recognition measures of the 
RT were used to measure visual memory. 
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Executive functioning. 
Within this domain the Digit Span backwards subtest of the WAIS-III, the TMT 
Part B, RCFT- copy, the interference trial of the Stroop and the COWA were included. 
The Digit Span backwards subtest evaluates the executive component of working 
memory, while the TMT-B is a measure of rapid set shifting and cognitive flexibility. 
The RCFT-copy assesses visuo-constructional skills and trial 3 of the Stroop test 
measures the capacity to focus on visual stimuli while filtering out interference or 
distracting information. Finally, the COWA assesses verbal fluency and cognitive 
flexibility by requiring the intrinsic generation of responses within a set of constraints. 
All of these measures have been used to assess executive functioning in previous studies 
(Busichio, et al., 2004; Claypoole, et al., 2007). 
Problem solving 
This domain was assessed using the Tower of London. This test assesses 
executive planning and problem solving. The number of perfect solutions (problems 
solved with a minimum of moves), and the number of moves required to solve novel 
problems were taken as a measure of the subject´s planning abilities (Joyce, et al., 
1996). 
Motor functioning. 
The Grooved pegboard (dominant and non-dominant hand) task is known to 
evaluate motor speed. The time for the dominant and non-dominant hand were 
recorded. 
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Design 
A cross-sectional study design was used. The examined variables included 
sociodemographic data (age, years of education, and work status), disease-related 
clinical variables (time since diagnosis, patient age at onset of symptoms and degree of 
fatigue), anxiety and depressive symptoms and scores on the neuropsychological tests. 
Data analysis 
Test performances were adjusted for age and gender, and transformed to a 
common metric (T scores) according to local normative data taken from prior studies 
(Santamarina-Perez, Eiroa-Orosa, et al., 2011). These scores were previously validated 
using a local healthy population sample of 250 subjects and no significant differences 
with the original parameters were confirmed. With these scores, a Summary Impairment 
Index, which represents the proportion of test scores outside normal limits (T score <40, 
Busichio, et al., 2004), was derived for each subject in each cognitive function. 
Summary indices reduce the probability of type 1 errors, by limiting the total number of 
comparisons conducted (Oyegbile et al., 2004). 
Pearson´s correlations were conducted to measure the relationship between 
summary impairment indices with sociodemographic and clinical information. Finally, 
we conducted multiple linear stepwise forward regression analyses to determine which 
variables could further explain the mentioned deficits. The significance level for all 
analyses was p<.05. All the statistical analyses were conducted using SPSS for 
Windows (version 18.0; SPSS Inc., Chicago). 
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Results 
As shown in Table 2, the sample was composed of relatively young women, 
most of whom had completed high school (in Spain at least 12 years of education are 
required to finish high school). They were mostly unemployed and had been diagnosed 
with CFS for an average of four years, meaning that they were young at disease onset. 
The HAD mean score was 11.3 (SD=4.3) for anxiety and 11.1 (SD=4.5) for depression, 
indicating high levels of both anxiety and depression. 75% of the patients were over the 
threshold of 9 points for anxiety and 73% for depression. Likewise; the FIS-40 scores 
(mean 132.9 (SD=21.8) in 75% of the patients exceeded the threshold of 120 proposed 
for the scale. 
 
Table 2.  Sociodemographic and clinical characteristics of the 68 patients.  
 
Variable  
Age (years)a 46.7 (8.34) 
Education (years)a 11.1 (3.7) 
Any active occupationb  16, 23.5 
Length of illness (months) a 47.3 (39.13) 
Age at onset of CFS (years)a 36.4 (11.2) 
HADS scorea 22.4 (7.9) 
FIS-40 scorea 132.9 (21.8) 
FIS: Fatigue Impact Scale; HADS: Hospital Anxiety and Depression Scale  
a mean (SD) 
bFrequency (percentages)
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Figure 1 shows the cognitive profile of the sample of CFS patients.  Means of 
the Summary Impairment Index for each cognitive function (representing proportion of 
test scores outside normal limits, T score <40, i.e. 1SD below the normative mean) 
obtained by CFS patients are shown. The mean for impaired attention is 54.43 and 
48.53 for motor functioning deficit, followed by 40.44 for speed of information 
processing, and 38.24 for executive functioning. 
Figure 1. Summary impairment indexes (mean of proportions of abnormal test scores). 
 
As can be seen in Table 3, bivariate Pearson correlations yielded significant 
results for attention (HAD: r=0.309, p<0.05, FIS: p=0.373, p<0.001), verbal memory 
(HAD: r=0.407, p<0.001, FIS: p=0.330, p<0.01) and executive functioning (HAD: 
r=0.236, p=0.056, FIS: p=0.397, p<0.001). Other variables included in our study, such 
as age, education and length of illness, were not associated with cognitive deficit. 
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Table 3.  Pearson correlations between sociodemographic and clinical information, and 
dysfunction index for each cognitive dimension. 
 
  
Attention 
Speed of 
information 
processing 
Verbal 
memory 
Visual 
memory 
Executive 
functioning 
Problem 
solving 
Motor 
functioning 
Age 0.160 0.084 -0.082 -0.058 0.076 0.076 0.111 
Education 
(years) 
-0.235 0.095 0.034 -0.154 -0.235 -0.116 -0.008 
Length of 
illness 
(months) 
-0.048 -0.085 -0.129 -0.171 -0.186 -0.029 -0.087 
Depression-
anxiety 
(HADS) 
0.309* 0.022 0.407*** 0.195 0.236☨ -0.211 0.185 
Degree of 
fatigue       
(FIS-40) 
0.373** -0.044 0.330** 0.066 0.397*** -0.047 0.118 
*p< .05 
**<.01 
***p<.001 
☨p=.056 
 
Finally, Table 4 shows results of the linear stepwise forward multiple 
regressions for the factors that had been found to be statistically significant in the 
correlation analyses. After controlling for all variables correlated with each domain, 
fatigue was associated with attention and executive functioning deficits. Depression 
predicted verbal memory dysfunction. Adjusted R2 showed low levels of explained 
variance (13-15%). 
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Table 4.  Results of the stepwise linear regression carried out with impaired cognitive functions 
 
 
Dimension R2 Adjusted R2 Variables Beta 95% CI p 
Attention 0.143 0.127     
   HAD  0.181 (excluded) 0.228 
   FIS 0.378 0.164-0.822 0.004 
Verbal memory 0.168 0.153     
   HAD  0.410 0.573-
20.190 
0.001 
   FIS 0.161 (excluded) 0.254 
Executive functioning  0.158 0.144     
   HAD 0.079 (excluded) 0.580 
   FIS 0.398 0.194-0.791 0.002 
 
 
Discussion 
In the present study we found individuals diagnosed with CFS showed diverse 
cognitive impairments, primarily in attention and motor functioning. The levels of 
attention dysfunction found in this study appear to be consistent with deficits found in 
other studies (Busichio, et al., 2004; Capuron, et al., 2006; Cockshell & Mathias, 2010; 
DeLuca, et al., 1997). In addition, attention was the primary impairment in our sample. 
This result suggest that attention deficit could be the primary cognitive dysfunction in 
CFS, and other cognitive deficits could be secondary to this dysfunction, in as found by 
Deluca et al (2006).  
 Participants showed poor performance in motor functioning, consistent with 
some studies (Busichio et al., 2004; Claypoole et al., 2007) but not others (Cockshell & 
Mathias, 2010). These inconsistencies may be the result of instrument heterogeneity in 
the assessment of this function. For instance, reaction time has been assessed using a 
reaction time test, (Majer et al., 2008), Finger Tapping (Mahurin et al., 2004), and 
Grooved Pegboard (Claypoole, et al., 2007), which may not measure the exact same 
construct. Another explanation of this poor motor functioning could be the possible 
effect of drug treatment. Grooved Pegboard is a sensitive instrument for measuring 
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general slowing due to medication (Lezak, 1995). The possible effects of medication on 
cognitive functioning was not controlled for in our study, which may not be a concern 
as Dickson et al. (2009) found no differences on any dependent variable when 
comparing groups of patients with and without medication. However, Dickson et al. did 
not include measures of motor functioning. We suggest the assessment of this function 
in future studies, while controlling for the effect of drugs. 
Patients with CFS showed poor results on tests that assess speed of information 
processing and executive functioning. These results are consistent with previous studies 
(Busichio, et al., 2004; Claypoole, et al., 2007; Dobbs, Dobbs, & Kiss, 2001), providing 
more evidence of cognitive deficits in people with CFS. 
As in previous studies, our data show memory being one of the less impaired 
dimensions among patients diagnosed with CFS (Busichio, et al., 2004; Lawrie, 
MacHale, Cavanagh, O'Carroll, & Goodwin, 2000; Ross, et al., 2001). Curiously, even 
though one of the major explicit complaints in patients with CFS is memory problems 
(Wearden & Appleby, 1996), little in the way empirical support for such memory 
complaints has been found in previous studies. Some studies suggest that memory 
problems could be the result of a general dysfunction in information processing and 
attention (DeLuca et al., 2004; Dickson, et al., 2009) an idea supported by our findings 
that although Although  memory scores were generally not low in our study, attention 
impairment was elevated. Consequently, memory problems experienced by CFS 
patients could be result of deficient acquisition secondary to impaired attention 
functions. 
In this study, we also analyzed the influence of clinical factors on cognitive 
dysfunction in CFS. An interesting result is that the level of fatigue would appear to be 
one of the main reasons for cognitive deficits in CFS. In fact, the level of fatigue could 
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be a manifestation of the disease severity, and cognitive deficits may be secondary to 
the pathophysiological processes of the disease itself, in agreement with Capuron et al. 
(2006).  
Anxiety and depression partially explained memory deficit, although were not 
involved in other cognitive impairments. In a study carried out by Dickson et al. (2009), 
patients with CFS showed elevated dysfunction on measures of memory, attention and 
visuo-constructional ability. After controlling for the effects of mood, patients showed 
dysfunction only in attention. Consequently, the memory complaints among CFS 
patients could be associated with mood and anxiety, and therefore be secondary to 
exogenous factors of the disease. In addition, impairments in memory functions have 
been found in depressed patients (Marvel & Paradiso, 2004).   
Our study was subject to some limitations. For instance, the exclusion of males 
could hamper the generalization of our results. As indicated in the methods section, this 
was done in order to homogenize the sample. Gender not only is related to cognitive 
function (Lezak, 1995), but also CFS prevalence (Jason, et al., 1999). This means that 
controlled studies that include men should be carried out. More factors such as 
personality traits, acute or progressive onset of the illness, sleep disturbances, possible 
effects of drugs and level of daily activity should be included in future studies in order 
to develop a more comprehensive model.  In conclusion, our sample of patients with 
CFS showed cognitive dysfunction primarily in attention and motor functioning. The 
attention deficits could be explained by the level of fatigue, which may be a 
manifestation of alterations in neural pathways underlying cognitive dysfunctions in 
CFS. Emotional factors appeared only to explain memory complaints. 
One of the possible explanations for the inconsistency of results from 
neuropsychological studies with CFS patients is the inclusion of heterogeneous samples. 
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Consequently, the main implication of this study may be the need to stratify patient 
groups taking into account common characteristics. We suggest that the sample is 
stratified depending on the presence of depression as assessed by an internationally 
recognized clinical interview. We also suggest that future studies identify patient groups 
according to the level of fatigue, which could be assessed through scales such as the 
FIS. This could help to identify specific cognitive profiles of each subgroup and, 
consequently, differential treatment approaches. Specifically, CFS patients with 
emotional disorders may benefit from psychotherapy and psychopharmacological 
interventions which could serve to improve the cognitive deficits associated with 
anxiety or depression.  Those CFS patients with higher levels of fatigue may benefit 
from cognitive rehabilitation in order to compensate for associated cognitive deficits. 
Implementing therapeutic physiotherapy programs, with the objective of improving the 
functional impairment usually associated with higher levels of fatigue, could also be of 
great interest. 
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